+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Daiichi Sankyo Co Ltd - logo

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 2271 Pages
  • Global
From
Skin Cancer Diagnostics Market Report 2026 - Product Thumbnail Image

Skin Cancer Diagnostics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 574 Pages
  • Global
From
Myasthenia Gravis Treatment Market: Forecast and Trends - Product Thumbnail Image

Myasthenia Gravis Treatment Market: Forecast and Trends

  • Report
  • November 2023
  • 120 Pages
  • Global
From
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1560 Pages
  • Global
From
Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1182 Pages
  • Global
From
Breast Cancer Monoclonal Antibodies Market 2024-2028 - Product Thumbnail Image

Breast Cancer Monoclonal Antibodies Market 2024-2028

  • Report
  • July 2024
  • 182 Pages
  • Global
From
Anticoagulants Market 2024-2028 - Product Thumbnail Image

Anticoagulants Market 2024-2028

  • Report
  • August 2024
  • 177 Pages
  • Global
From
Thrombosis Drugs Market 2024-2028 - Product Thumbnail Image

Thrombosis Drugs Market 2024-2028

  • Report
  • August 2024
  • 144 Pages
  • Global
From
Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 1814 Pages
  • Global
From
Antibody Drug Conjugates Market Size, Share & Trends Analysis Report by Application (Blood Cancer, Urothelial Carcinoma, Ovarian Cancer, Breast Cancer, Other Cancer), Product, Payload, Technology, Distribution Channel and Region with Growth Forecasts, 2025-2033 - Product Thumbnail Image

Antibody Drug Conjugates Market Size, Share & Trends Analysis Report by Application (Blood Cancer, Urothelial Carcinoma, Ovarian Cancer, Breast Cancer, Other Cancer), Product, Payload, Technology, Distribution Channel and Region with Growth Forecasts, 2025-2033

  • Report
  • November 2025
  • 150 Pages
  • Global
From
Pulmonary Arterial Hypertension (PAH) Drugs Market 2024-2028 - Product Thumbnail Image

Pulmonary Arterial Hypertension (PAH) Drugs Market 2024-2028

  • Report
  • July 2024
  • 180 Pages
  • Global
From
Antithrombotic/Anticoagulant Drugs: Technologies and Global Markets - Product Thumbnail Image

Antithrombotic/Anticoagulant Drugs: Technologies and Global Markets

  • Report
  • October 2023
  • 157 Pages
  • Global
From
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 820 Pages
  • Global
From
Neuroendocrine Tumors Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Neuroendocrine Tumors Therapeutics - Global Strategic Business Report

  • Report
  • March 2026
  • 171 Pages
  • Global
From
Chemotherapy Treatment - Global Strategic Business Report - Product Thumbnail Image

Chemotherapy Treatment - Global Strategic Business Report

  • Report
  • March 2026
  • 188 Pages
  • Global
From
Cancer Antibody Drug Conjugates Market - Global Strategic Business Report - Product Thumbnail Image

Cancer Antibody Drug Conjugates Market - Global Strategic Business Report

  • Report
  • March 2026
  • 482 Pages
  • Global
From
Angiosarcoma Treatment Market - Global Strategic Business Report - Product Thumbnail Image

Angiosarcoma Treatment Market - Global Strategic Business Report

  • Report
  • March 2026
  • 390 Pages
  • Global
From
Cytotoxic Drugs - Global Strategic Business Report - Product Thumbnail Image

Cytotoxic Drugs - Global Strategic Business Report

  • Report
  • March 2026
  • 462 Pages
  • Global
From
Esophageal Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Esophageal Cancer Drugs - Global Strategic Business Report

  • Report
  • March 2026
  • 269 Pages
  • Global
From
Loading Indicator